Government must act on new hepatitis C meds, says peak body
The Federal Government needs to list new hepatitis C medicines on the PBS without further delay, according to the peak body representing the interests of a quarter of a million …
$5 million in grants to Australian research on type 2 diabetes
Three Australian research teams have been awarded grants as part of a global effort to combat the growing incidence of type 2 diabetes, which affects more than 300 million people …
Biosimilars: PBAC ‘a’ flags infliximab
The PBAC today recommended that Inflectra (infliximab), the first monoclonal antibody ‘mAb’ biosimilar registered in Australia, be added to the Pharmaceutical Benefits Scheme. The recommendation is the first step towards …
Long working hours linked to higher risk of stroke
Working more than 55 hours is linked to a huge increased risk of stroke and also coronary heart disease, according to a study published in The Lancet. The study—the largest …
Michael Williams fastest pharmacist at Snow Business
Eltham pharmacist Michael Williams has taken out the title of fastest pharmacist, winning the Medici Capital Pharmacy Ski Race for 2015. The annual race was held at Mt Buller this …
Clinical tips: men and cancer explained
Sometimes men need to be scared into taking action when they present with pain and other symptoms, writes Karalyn Huxhagen Cancer in males can be in many forms, some of …
Highest dementia in world in remote Aboriginal communities
Research by The University of Western Australia’s Centre for Health and Ageing has confirmed that the incidence of dementia in remote Aboriginal communities is the highest in the world, with …
Discount Drug Stores holds breast health clinics
Discount Drug Stores is urging Australians to become educated on their breast health by launching its first Spotlight On Breast Health Clinics throughout 115 stores across Australia in August and …
GBMA welcomes infliximab biosimilar listing
The Generic and Biosimilar Medicines Association has welcomed the approval of biosimilar infliximab, Inflectra. Inflectra is the first biosimilar infliximab to be approved in Australia, providing an alternative, affordable treatment …
Chilli receptors linked to satiety, disrupted in high-fat diet
University of Adelaide researchers have discovered a high-fat diet may impair important receptors located in the stomach that signal fullness. Published in the journal PLOS ONE, researchers from the University’s …
Last call for macular disease photo competition entries
As head judge of the mEYE World Photographic Competition, Ita Buttrose is calling for entries to raise awareness of macular disease in her role as Patron of the Macular Disease …
Primary health care reform needed now: Quilty
There is an ongoing need for genuine primary health care reform, and the Guild is actively playing a part in the national debate about the direction that reform needs to …